Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: February 26, 2018
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: April 14, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
Journal: Journal of the American College of Cardiology
Published: March 15, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 24, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Journal: Journal of the American College of Cardiology
Published: October 11, 2016
Elective or Emergency Use of Mechanical Circulatory Support Devices During Transcatheter Aortic Valve Replacement.
Journal: Journal of interventional cardiology
Published: August 24, 2016
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.
Journal: Stem cells translational medicine
Published: July 06, 2016
Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
Published: March 27, 2016
Emergent Percutaneous Biventricular Support during Transcatheter Aortic Valve Replacement.
Journal: The Journal of heart valve disease
Published: February 24, 2016
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Journal: Oncotarget
Published: December 20, 2015
Last Updated: 09/26/2026